We are live on
!
Find out more
QC
Quantessence Capital Portfolio holdings
AUM
$20.5M
1-Year Est. Return
71.02%
This Fund
S&P 500
This Quarter
Est. Return
+14.43%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$60.2M
(-15%)
Cap. Flow
-$87.3M
Cap. Flow
% of AUM
-25.71%
Top 10 Holdings %
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AZEK
The AZEK Co
AZEK
|
+$58.6M |
| 2 |
RDFN
Redfin
RDFN
|
+$35.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.53M |
| 4 |
Sprouts Farmers Market
SFM
|
+$7.45M |
| 5 |
Insmed
INSM
|
+$5.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$30.3M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$12.3M |
| 3 |
ExxonMobil
XOM
|
+$11.3M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$10.8M |
| 5 |
Pfizer
PFE
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 31.47% |
| 2 | Real Estate | 13.23% |
| 3 | Healthcare | 10.04% |
| 4 | Financials | 9.26% |
| 5 | Consumer Discretionary | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
The Mosaic Company
MOS
$7.09B
| – | – |
-63,336
| Closed | -$1.71M |
|
352
Motorcar Parts of America
MPAA
$261M
| – | – |
-11,298
| Closed | -$107K |
|
353
Monolithic Power Systems
MPWR
$65.5B
| – | – |
-1,816
| Closed | -$1.05M |
|
354
Moderna
MRNA
$21.5B
| – | – |
-31,821
| Closed | -$902K |
|
355
Microsoft
MSFT
$2.84T
| – | – |
-13,450
| Closed | -$5.05M |
|
356
MSC Industrial Direct
MSM
$7.02B
| – | – |
-3,600
| Closed | -$280K |
|
357
M&T Bank
MTB
$36.2B
| – | – |
-22,800
| Closed | -$4.08M |
|
358
MGIC Investment
MTG
$6.27B
| – | – |
-65,500
| Closed | -$1.62M |
|
359
Meritage Homes
MTH
$4.87B
| – | – |
-3,960
| Closed | -$281K |
|
360
MasTec
MTZ
$26.7B
| – | – |
-9,111
| Closed | -$1.06M |
|
361
Microvast
MVST
$267M
| – | – |
-77,362
| Closed | -$90.5K |
|
362
Myomo
MYO
$37.5M
| – | – |
-18,255
| Closed | -$87.8K |
|
363
Newmont
NEM
$99.5B
| – | – |
-7,794
| Closed | -$376K |
|
364
Nike
NKE
$61.9B
| – | – |
-52,200
| Closed | -$3.31M |
|
365
Insight Enterprises
NSIT
$3.55B
| – | – |
-2,900
| Closed | -$435K |
|
366
Nucor
NUE
$56.4B
| – | – |
-8,500
| Closed | -$1.02M |
|
367
nVent Electric
NVT
$24.5B
| – | – |
-19,844
| Closed | -$1.04M |
|
368
NorthWestern Energy
NWE
$4.48B
| – | – |
-6,500
| Closed | -$376K |
|
369
Organon & Co
OGN
$3.55B
| – | – |
-55,200
| Closed | -$822K |
|
370
ON Semiconductor
ON
$33.8B
| – | – |
-25,647
| Closed | -$1.04M |
|
371
Oportun Financial
OPRT
$257M
| – | – |
-24,910
| Closed | -$137K |
|
372
Old Republic International
ORI
$10.3B
| – | – |
-5,400
| Closed | -$212K |
|
373
Otis Worldwide
OTIS
$27.6B
| – | – |
-13,700
| Closed | -$1.41M |
|
374
Par Pacific Holdings
PARR
$3.88B
| – | – |
-13,100
| Closed | -$187K |
|
|
375
Pfizer
PFE
$140B
| – | – |
-420,000
| Closed | -$10.6M |
|
Similar funds
FS
BC
HAM
DP
SPC
IW
SRHG
MPW
Quantessence Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Quantessence Capital held 483 positions worth $340M, down 15% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Quantessence Capital withdrew a net $87.3M in Q2 2025, closing 302 positions and reducing 18 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $30.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 11% a quarter earlier, followed by Real Estate and Healthcare.
Against the trend, Quantessence Capital opened a new position in The AZEK Co worth $63.6M.
- Quantessence Capital's largest Q2 2025 buy was The AZEK Co: 1,170,131 shares worth $63.6M.
- Quantessence Capital added most to Merck in Q2 2025, an estimated $3.19M increase.
- Quantessence Capital's biggest Q2 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $1.84M.
- Quantessence Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $30.3M.
- Quantessence Capital's ten largest holdings make up 46% of its $340M portfolio in Q2 2025.
- Quantessence Capital opened 151 new positions and closed 302 in Q2 2025.
- Quantessence Capital's portfolio value fell 15% quarter-over-quarter to $340M.
Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.